Health Canada may give cannabis license holders a deferred deadline for paying annual cannabis regulatory fees in light of the COVID-19 pandemic.

The federal health department is holding a two-week consultation to gauge industry feedback.

A notice of intent for the consultation was given in the June 13 edition of the Canada Gazette.

The possible deferral would apply to regulatory fees for the 2020-2021 year, for federal cannabis licenses issued before April 1, 2020, according to Health Canada’s consultation webpage.

In a statement, the industry group Cannabis Council of Canada said it had “mixed views” about the proposal to defer the fees, which amount to 2.3% of annual gross revenue for standard cannabis license holders.

“In the grand scheme of meaningful liquidity relief this deferral proposal on its own falls well short of the need, but within the narrower range of options available specifically to Health Canada, it is some measure of recognition of the challenges our sector is facing,” said council CEO George Smitherman in the statement.

Interested parties may email [email protected] with the subject line “COVID-19: Notice of intent to consult on Health Canada’s proposal to provide the cannabis industry with financial relief amid the COVID-19 pandemic.”

An online questionnaire is also available.

The consultation period will close on June 27.

Pure Cannabis Hemp Oil

• Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

• Clinically proven therapeutic effects.

• Relieves anxiety and stress

• Eliminates chronic pain and aches

• Regulates mood and sleep patterns

• Enhances focus and clarity
  
  
  

more details, George Scorsis
Originally posted on via Cannabis Industry News